Jacobs SE, Lamson DM, Kirsten S, Walsh TJ. Human rhinoviruses. Clin Microbiol Rev. 2013;26(1):135–62.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Casanova V, Sousa FH, Stevens C, Barlow PG. Antiviral therapeutic approaches for human rhinovirus infections. Future Virol. 2018;13(7):505–18.

Article  CAS  PubMed  PubMed Central  Google Scholar 

McLean GR. Developing a vaccine for human rhinoviruses. J Vaccines Immun. 2014;2(3):16.

Article  PubMed  PubMed Central  Google Scholar 

Feddema JJ, Claassen E. Prevalence of viral respiratory infections amongst asthmatics: Results of a meta-regression analysis. Respir Med. 2020;173:106020.

Article  CAS  PubMed  Google Scholar 

Thomas BJ, Porritt RA, Hertzog PJ, Bardin PG, Tate MD. Glucocorticosteroids enhance replication of respiratory viruses: effect of adjuvant interferon. Sci Reports. 2014;4(1):1–11.

Google Scholar 

Papi A, Contoli M, Adcock IM, Bellettato C, Padovani A, Casolari P, et al. Rhinovirus infection causes steroid resistance in airway epithelium through nuclear factor κb and c-Jun N-terminal kinase activation. J Allergy Clin Immunol. 2013;132(5):1075–85.

Article  CAS  PubMed  Google Scholar 

Edwards MR, Walton RP, Jackson DJ, Feleszko W, Skevaki C, Jartti T, et al. The potential of anti-infectives and immunomodulators as therapies for asthma and asthma exacerbations. Allergy. 2018;73(1):50–63.

Article  CAS  PubMed  Google Scholar 

Egorova A, Kazakova E, Jahn B, Ekins S, Makarov V, Schmidtke M. Novel pleconaril derivatives: Influence of substituents in the isoxazole and phenyl rings on the antiviral activity against enteroviruses. Eur J Med Chem. 2020;188:112007.

Article  CAS  PubMed  Google Scholar 

Danov O, Lasswitz L, Obernolte H, Hesse C, Braun A, Wronski S, Sewald K. Rupintrivir reduces RV-induced TH-2 cytokine IL-4 in precision-cut lung slices (PCLS) of HDM-sensitized mice ex vivo. Respir Res. 2019;20:1–9.

Article  CAS  Google Scholar 

Turner RB, Wecker MT, Pohl G, Witek TJ, McNally E, St. George R, et al. Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial. JAMA. 1999;281(19):1797–804.

Article  CAS  PubMed  Google Scholar 

Gupta SC, Patchva S, Koh W, Aggarwal BB. Discovery of curcumin, a component of the golden spice, and its miraculous biological activities. Clin Exp Pharmacol Physiol. 2012;39(3):283.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen DY, Shien JH, Tiley L, Chiou SS, Wang SY, Chang TJ, et al. Curcumin inhibits influenza virus infection and haemagglutination activity. Food Chem. 2010;119(4):1346–51.

Article  CAS  Google Scholar 

Dai J, Gu L, Su Y, Wang Q, Zhao Y, Chen X, et al. Inhibition of curcumin on influenza A virus infection and influenzal pneumonia via oxidative stress, TLR2/4, p38/JNK MAPK and NF-κB pathways. Int Immunopharmacol. 2018;54:177–87.

Article  CAS  PubMed  Google Scholar 

Han S, Xu J, Guo X, Huang M. Curcumin ameliorates severe influenza pneumonia via attenuating lung injury and regulating macrophage cytokines production. Clin Exp Pharmacol Physiol. 2018;45(1):84–93.

Article  CAS  PubMed  Google Scholar 

Lai Y, Yan Y, Liao S, Li Y, Ye Y, Liu N, et al. 3D-quantitative structure–activity relationship and antiviral effects of curcumin derivatives as potent inhibitors of influenza H1N1 neuraminidase. Arch Pharm Res. 2020;43(5):489–502.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ou JL, Mizushina Y, Wang SY, Chuang DY, Nadar M, Hsu WL. Structure–activity relationship analysis of curcumin analogues on anti-influenza virus activity. FEBS J. 2013;280(22):5829–40.

Article  CAS  PubMed  Google Scholar 

Xu Y, Liu L. Curcumin alleviates macrophage activation and lung inflammation induced by influenza virus infection through inhibiting the NF-κB signaling pathway. Influenza Other Respir Viruses. 2017;11(5):457–63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Obata K, Kojima T, Masaki T, Okabayashi T, Yokota S, Hirakawa S, et al. Curcumin prevents replication of respiratory syncytial virus and the epithelial responses to it in human nasal epithelial cells. PLoS ONE. 2013;8(9):e70225.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang XX, Li CM, Li YF, Wang J, Huang CZ. Synergistic antiviral effect of curcumin functionalized graphene oxide against respiratory syncytial virus infection. Nanoscale. 2017;9(41):16086–92.

Article  CAS  PubMed  Google Scholar 

Zhang C, Zhang K, Zang G, Chen T, Lu N, Wang S, et al. Curcumin inhibits replication of human parainfluenza virus type 3 by affecting viral inclusion body formation. Biomed Res Int. 2021;2021(1):1807293.

PubMed  PubMed Central  Google Scholar 

Wen CC, Kuo YH, Jan JT, Liang PH, Wang SY, Liu HG, et al. Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus. J Med Chem. 2007;50(17):4087–95.

Article  CAS  PubMed  Google Scholar 

Marín-Palma D, Tabares-Guevara JH, Zapata-Cardona MI, Flórez-álvarez L, Yepes LM, Rugeles MT, et al. Curcumin inhibits in vitro SARS-CoV-2 infection in vero E6 cells through multiple antiviral mechanisms. Molecules. 2021;26(22):6900.

Article  PubMed  PubMed Central  Google Scholar 

Abidi A, Gupta S, Agarwal M, Bhalla HL, Saluja M. Evaluation of efficacy of curcumin as an add-on therapy in patients of bronchial asthma. J Clin Diagn Res. 2014;8(8):HC19.

PubMed  PubMed Central  Google Scholar 

Edin J, Mitja K, Nermina A, Jasmina N, Mona A-A, Azra J, et al. Curcumin improves step 4 asthma treatment: placebo-controlled, single blind study. Pulm Resp Med Int J. 2019;2(1):5–9.

Google Scholar 

Priyadarsini KI. The chemistry of curcumin: from extraction to therapeutic agent. Molecules. 2014;19(12):20091.

Article  PubMed  PubMed Central  Google Scholar 

Górnicka J, Mika M, Wróblewska O, Siudem P, Paradowska K. Methods to improve the solubility of curcumin from turmeric. Life. 2023;13(1):207.

Article  PubMed  PubMed Central  Google Scholar 

Noureddin SA, El-Shishtawy RM, Al-Footy KO. Curcumin analogues and their hybrid molecules as multifunctional drugs. Eur J Med Chem. 2019;182:111631.

Article  CAS  PubMed  Google Scholar 

Leong SW, Mohd Faudzi SM, Abas F, Mohd Aluwi MFF, Rullah K, Wai LK, et al. Synthesis and sar study of diarylpentanoid analogues as new anti-inflammatory agents. Molecules. 2014;19(10):16058–81.

Article  PubMed  PubMed Central  Google Scholar 

Leong SW, Mohd Faudzi SM, Abas F, Mohd Aluwi MFF, Rullah K, Lam KW, et al. Nitric oxide inhibitory activity and antioxidant evaluations of 2-benzoyl-6-benzylidenecyclohexanone analogs, a novel series of curcuminoid anddiarylpentanoid derivatives. Bioorg Med Chem Lett. 2015;25(16):3330–7.

Article  CAS  PubMed  Google Scholar 

Azmi F, Leong SW, Abas F, Ming OH, Perimal EK, Akira A, et al. Antinociceptive effect of 2-benzoyl-6-(3,4-dihydroxybenzylidene)cyclohexen-1-ol on nociception induced models in mice. J Pharmacol Toxicol Investig. 2016;2(1):1–9.

Google Scholar 

Kamarudin N, Hisamuddin N, Ong HM, Ahmad Azmi AF, Leong SW, Abas F, et al. Analgesic effect of 5-(3,4-Dihydroxyphenyl)-3-hydroxy-1-(2-hydroxyphenyl)penta-2,4-dien-1-one in experimental animal models of nociception. Molecules. 2018;23(9):2099.

Article  PubMed  PubMed Central  Google Scholar 

Liew KY, Rosly NA, Abas F, Leong SW, Israf DA, Tham CL. Effect of diarylpentanoid analogues on lipopolysaccharide-induced interleukin-6 and interleukin-8 gene expression in airway inflammation. Malaysian J Med Heal Sci. 2019;15(SP2):10–7.